BridgeMD
New treatment option for Wound Infection, Surgical
Official title Comparison of Frequency of Wound Infection Between Open and Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07103707
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare the frequency of wound infection between open and laparoscopic cholecystectomy in adult patient aged 18- 65 years with symptomatic cholelithiasis admitted through OPD the main question it aims to answer are Does there is difference in the frequency of wound infection in patients with open cholecystectomy as compared to laparoscopic cholecystectomy Researcher will compare the frequency of wound infection in participant undergoing open and laparoscopic cholecystectomy to see there is difference in frequency of wound infection between open and laparoscopic cholecystectomy Participants will be asked To Visit OPD after 1 week for follow up Keep record of symptoms like erythema, pain, cloudy drainage from the incision site
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Both genders
- Patients aged 18 to 65 years
- Symptomatic cholelithiasis as per operational definition
- Undergoing cholecystectomy (open/laparoscopic)
- ASA score I/II (Annexure-II)
You likely can't join if
- ● H/o diabetes mellitus
- H/o immunocompromised state (e.g. HIV, steroid use)
- H/o acute cholecystitis
- H/o empyema gallbladder
- H/o gallbladder perforation ● H/o choledocholithiasis
- H/o portal hypertension
See the full eligibility criteria
- Both genders
- Patients aged 18 to 65 years
- Symptomatic cholelithiasis as per operational definition
- Undergoing cholecystectomy (open/laparoscopic)
- ASA score I/II (Annexure-II)
- ● H/o diabetes mellitus
- H/o immunocompromised state (e.g. HIV, steroid use)
- H/o acute cholecystitis
- H/o empyema gallbladder
- H/o gallbladder perforation ● H/o choledocholithiasis
- H/o portal hypertension
- H/o abnormal blood clotting profiles (PTT \>15 seconds, APTT \>20 seconds)
- H/o pregnancy on HCG
The study team makes the final eligibility decision.
Where it's taking place
- Peshawar, Khyber Pakhtunkhwa, Pakistan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Peshawar, Khyber Pakhtunkhwa, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.